NO20022109D0 - Anvendelse av treosulfan for behandling av pasienter för benmargs- eller blodstamcelletansplantasjon - Google Patents

Anvendelse av treosulfan for behandling av pasienter för benmargs- eller blodstamcelletansplantasjon

Info

Publication number
NO20022109D0
NO20022109D0 NO20022109A NO20022109A NO20022109D0 NO 20022109 D0 NO20022109 D0 NO 20022109D0 NO 20022109 A NO20022109 A NO 20022109A NO 20022109 A NO20022109 A NO 20022109A NO 20022109 D0 NO20022109 D0 NO 20022109D0
Authority
NO
Norway
Prior art keywords
treosulfan
bone marrow
patients
treatment
stem cell
Prior art date
Application number
NO20022109A
Other languages
English (en)
Other versions
NO329616B1 (no
NO20022109L (no
Inventor
Joachim Baumgart
Original Assignee
Medac Klinische Spezialpraep
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medac Klinische Spezialpraep filed Critical Medac Klinische Spezialpraep
Publication of NO20022109D0 publication Critical patent/NO20022109D0/no
Publication of NO20022109L publication Critical patent/NO20022109L/no
Publication of NO329616B1 publication Critical patent/NO329616B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20022109A 1999-11-05 2002-05-02 Anvendelse av treosulfan for fremstilling av et farmasøytisk preparat til bruk i forbindelse med allogen transplantasjon av benmarg eller hematopoetiske stamceller NO329616B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19953517A DE19953517C1 (de) 1999-11-05 1999-11-05 Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation
PCT/EP2000/010871 WO2001032154A2 (de) 1999-11-05 2000-11-03 Verwendung von treosulfan zur konditionierung von patienten vor knochenmarktransplantation oder blutstammzelltransplantation

Publications (3)

Publication Number Publication Date
NO20022109D0 true NO20022109D0 (no) 2002-05-02
NO20022109L NO20022109L (no) 2002-07-01
NO329616B1 NO329616B1 (no) 2010-11-22

Family

ID=7928187

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20022109A NO329616B1 (no) 1999-11-05 2002-05-02 Anvendelse av treosulfan for fremstilling av et farmasøytisk preparat til bruk i forbindelse med allogen transplantasjon av benmarg eller hematopoetiske stamceller
NO2019032C NO2019032I1 (no) 1999-11-05 2019-07-23 Treosulfan

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2019032C NO2019032I1 (no) 1999-11-05 2019-07-23 Treosulfan

Country Status (16)

Country Link
US (1) US7199162B1 (no)
EP (1) EP1227808B1 (no)
JP (1) JP4846151B2 (no)
AT (1) ATE251455T1 (no)
AU (1) AU777527B2 (no)
BG (1) BG65845B1 (no)
CA (1) CA2389896C (no)
CZ (1) CZ299701B6 (no)
DE (2) DE19953517C1 (no)
EA (1) EA004543B1 (no)
ES (1) ES2208435T3 (no)
HU (2) HU227332B1 (no)
NO (2) NO329616B1 (no)
PL (1) PL212132B1 (no)
UA (1) UA73961C2 (no)
WO (1) WO2001032154A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237146A1 (de) 2002-08-13 2004-03-04 Medac Gesellschaft für klinische Spezialpräparate mbH Verwendung von Treosulfan und Derivaten davon zur Behandlung der Multiplen Sklerose
EA202190615A1 (ru) * 2018-09-26 2021-06-24 Медак Гезельшафт Фюр Клинише Шпециальпрепарате Мбх Кристаллическая форма треосульфана
EP3856252A1 (en) 2018-09-26 2021-08-04 medac Gesellschaft für klinische Spezialpräparate mbH Solution comprising treosulfan
EP3856151B1 (en) 2018-09-26 2023-08-23 medac Gesellschaft für klinische Spezialpräparate mbH Lyophilisate of treosulfan

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
DE4421391C1 (de) * 1994-06-18 1995-11-30 Gsf Forschungszentrum Umwelt Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression
WO2000045842A2 (en) * 1999-02-04 2000-08-10 The General Hospital Corporation Methods for human allografting

Also Published As

Publication number Publication date
ATE251455T1 (de) 2003-10-15
PL356240A1 (en) 2004-06-28
CZ299701B6 (cs) 2008-10-22
WO2001032154A3 (de) 2002-01-24
ES2208435T3 (es) 2004-06-16
HUS1900041I1 (hu) 2019-10-28
EA004543B1 (ru) 2004-06-24
WO2001032154A2 (de) 2001-05-10
EA200200535A1 (ru) 2002-10-31
CA2389896A1 (en) 2001-05-10
UA73961C2 (uk) 2005-10-17
PL212132B1 (pl) 2012-08-31
HU227332B1 (en) 2011-03-28
BG106772A (bg) 2003-02-28
HUP0203277A2 (en) 2003-01-28
CA2389896C (en) 2007-04-10
US7199162B1 (en) 2007-04-03
AU777527B2 (en) 2004-10-21
DE50004024D1 (de) 2003-11-13
NO2019032I1 (no) 2019-07-23
JP4846151B2 (ja) 2011-12-28
JP2003513034A (ja) 2003-04-08
BG65845B1 (bg) 2010-03-31
EP1227808B1 (de) 2003-10-08
EP1227808A2 (de) 2002-08-07
AU1391801A (en) 2001-05-14
NO329616B1 (no) 2010-11-22
NO20022109L (no) 2002-07-01
DE19953517C1 (de) 2001-08-09
CZ20021562A3 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
HUS1900041I1 (hu) Treoszulfán alkalmazása betegek csontvelõ- és vér õssejt-transzplantáció elõtti kondicionálására
DK1131096T3 (da) Anti-CD20-antistofbehandling af patienter, der modtager knoglemarvs- eller periferisk blodstamcelletransplantationer
EA199901107A1 (ru) Системы и устройства для лечения переломов костей или больных костей с помощью расширяемых тел (варианты), стерильный набор инструментов для введения в кость (варианты)
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
DE60018044D1 (de) Neue biomaterialien
IL197686A0 (en) Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
SE9702860D0 (sv) New use
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
DE69924715D1 (de) Verwendung von angiotensin analogen zur herstellung eines arzneimittels zur steigerung des ueberlebens der weissen blutzellen und mobilisierung von haematopoietischen stammzellen nach einer chemotherapeutischen behandlung
WO2004104166A3 (en) Administration of hyaluronic acid to enhance the function of transplanted stem cells
NO20052505L (no) Ny bruk av dextran-sulfat
DE60106002D1 (de) Behandlung von hematopoietischen zellen mit cxcr4 agonisten
DE69634982D1 (de) Verfahren zur steigerung von hematopoietischen zellen
ATE426402T1 (de) Medizinische zusammensetzungen enthaltend 2-amino-2-a2-(4-octylphenyl)ethylupropan-1,3-di l
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
WO2005017160A3 (en) Mobilization of hematopoietic cells
ATE297217T1 (de) Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
DK0671909T3 (da) Syndecanstimulering af cellulær differentiering
DE60042210D1 (de) Verwendung von cytokinen, zellen und mitogene zur hemmung der graft-versus-host krankheit
WO2003001877A3 (en) Methods for the diagnosis and treatment of cardiac tissue rejection
BR9913846A (pt) Antagonista receptor de quemocina e ciclosporina em terapia combinada
GB9710698D0 (en) Composition
DE69931148D1 (de) Behandlung von hiv infektionen
ES2188754T3 (es) Componente b como cicatrizante.

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: TREOSULFAN; REG. NO/DATE: EU/1/18/1351 20190620

Spc suppl protection certif: 2019032

Filing date: 20190723

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MEDAC GESELLSCHAFT FUER KLINISCHE SPEZIALPRAEP, DE

MK1K Patent expired